Clinical Trials Directory

Trials / Conditions / Takayasu Arteritis (TAK)

Takayasu Arteritis (TAK)

7 registered clinical trials studyying Takayasu Arteritis (TAK) — 5 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingEfficacy and Safety of Vunakizumab and Ivarmacitinib in the Treatment of Active Takayasu's Arteritis
NCT07451665
Chinese SLE Treatment And Research GroupPhase 4
RecruitingInvestigating Management, Perspectives and Attitudes Towards Care in Takayasu Arteritis
NCT07351422
University of Edinburgh—
Not Yet RecruitingThe Efficacy and Safety of Deucravacitinib in Takayasu's Arteritis
NCT07013838
Chinese SLE Treatment And Research GroupPhase 4
Not Yet RecruitingA Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic
NCT06766552
Second Affiliated Hospital, School of Medicine, Zhejiang University—
Active Not RecruitingEvaluation of Platelet Aggregability in Patients with Takayasu's Arteritis
NCT06807788
Jose Carlos Nicolau—
Active Not RecruitingA Study to Evaluate the Efficacy and Safety of Upadacitinib in Participants With Takayasu Arteritis (TAK)
NCT04161898
AbbViePhase 3
RecruitingVasculitis Pregnancy Registry
NCT02593565
University of Pennsylvania—